Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Jun 14, 2023; 29(22): 3508-3518
Published online Jun 14, 2023. doi: 10.3748/wjg.v29.i22.3508
Table 2 Treatment times previously of the enrolled patients and its eradication rates
Treatment times
500 mg b.i.d.
750 mg b.i.d.
500 mg t.i.d.
193.4% (127/136)97.5% (77/79)92.6% (87/94)
283.3% (15/18)87.5% (28/32)90.9% (20/22)
≥ 3100% (3/3)71.4% (5/7)100% (3/3)
Rescue therapy185.7% (18/21)84.6% (33/39)92.0% (23/25)